Appili Therapeutics Inc.APLI.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · appilitherapeutics.com
Appili Therapeutics Inc. is a Canadian biopharmaceutical company focused on developing anti-infective drugs and medical countermeasures for infectious diseases. The company's pipeline includes an FDA-approved metronidazole suspension, a biodefense vaccine candidate, and a topical antiparasitic treatment.
Key ratios
FCF / Sales
-5.5%TTM
2025
863.0%2024
-301.4%2023
-3022.4%
ROA
-292.0%TTM
2025
-278.7%2024
-217.7%2023
-86.7%
Recent news
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2027
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
Track APLI.TO in your journal
Save it to a watchlist, run a reverse DCF, and keep your notes on the company in one place. Free to start.
Figures are sourced from third parties and shown for research only. They may be delayed or incomplete, and nothing on this page is investment advice or a recommendation to buy or sell. Read the full disclaimer